METTL3 and breast carcinoma: METTL3 subsequently increases HBXIP expression by increasing m6A modification, thereby creating a positive feedback loop consisting of HBXIP/miR-let-7g/METLL3/HBXIP that accelerates breast cancer cell proliferation (Cai et al., 2018).